Background. Polycystic ovary syndrome (PCOS) is the most common female endocrine disease. Cangfu Daotan Decoction (CDD) can effectively relieve the clinical symptoms of PCOS patients. Methods. To explore the active ingredients and related pathways of CDD for treating PCOS, a network pharmacology-based analysis was carried out. e active ingredients of CDD and their potential targets were obtained from the TCM system pharmacology analysis platform. e obtained PCOS-related genes from OMIM and GeneCards were imported to establish protein-protein interaction networks in STRING. Finally, GO analysis and significant pathway analysis were conducted with the RStudio (Bioconductor) database. Results. A total of 111 active compounds were obtained from 1433 ingredients present in the CDD, related to 118 protein targets. In addition, 736 genes were found to be closely related to PCOS, of which 44 overlapped with CDD and were thus considered therapeutically relevant. Pathway enrichment analysis identified the AGE-RAGE signalling pathway in diabetic complications, endocrine resistance, the IL-17 signalling pathway, the prolactin signalling pathway, and the HIF-1 signalling pathway. Moreover, PI3K-Akt, insulin resistance, Toll-like receptor, MAPK, and AGE-RAGE were related to PCOS and treatment. Conclusions. CDD can effectively improve the symptoms of PCOS, and our network pharmacological analysis lays the foundation for future clinical research.
Background
Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women and is characterized by abnormal adrenal and ovarian androgen secretion, ovulatory dysfunction, menstrual irregularity, acne [1] , and polycystic ovarian morphological features, and in a significant proportion of patients, insulin resistance, with a prevalence between 5% and 15% [2, 3] . Although for a long period, studies on PCOS have focused on reproductive disorders [4] , recent evidence suggests that PCOS is a heterogeneous disorder associated with a large number of severe metabolic implications as well as cardiovascular disease for affected women [5] , which brings a heavy burden to the patient's family and to society. However, there is a generally poor understanding of its aetiology [6] . Genome-wide and molecular mechanism studies have identified certain candidate gene targets, although their role in the development of PCOS is still largely unknown; thus, early diagnosis, effective treatment, and the elucidation of underlying mechanisms are necessary [7, 8] .
In the past few decades, oral contraceptive pills (OCPs) have been widely used in PCOS patients to regulate their menstrual cycles and reduce hyperandrogenism [4] . Clomiphene citrate and letrozole have both been used to induce ovulation in PCOS patients with fertility problems [9] [10] [11] . However, reports have been coming in regarding the side effects of OCPs in increasing the risk of venous thromboembolism (VTE) [12, 13] . Moreover, some experts have called attention to the unclear long-term risk-benefit ratio [11, 14, 15] . Due to the limitations of current treatments, traditional Chinese medicine (TCM) treatment for PCOS has become an important alternative therapy.
ere is no specific Chinese medical term referring to "PCOS" in the ancient books of Chinese medicine. According to the clinical characteristics of PCOS, it is attributed to the category of irregular menstruation, infertility, obesity, etc. For thousands of years, TCM has been used to treat menstrual disorders, infertility, and obesity. ere are a number of herbal formulas in treating the above diseases. A study showed that herbal medicine administration significantly relieved some of the symptoms of PCOS [16] . Specifically, the CDD consists of nine herbs: Atractylodes lancea ( unb.) Dc (Cangzhu), Cyperi Rhizoma (Xiangfu), Arisaematis Rhizoma (Dannanxing), Arum ternatum unb (Banxia), Zingiber officinale Roscoe (Shengjiang), Citrus reticulata (Chenpi), Aurantii Fructus (Zhike), Poria cocos (Schw.) Wolf (Fuling), and Licorice (Gancao) and is one of the most common prescriptions for phlegm and dampnesstype PCOS patients [17] . Another study showed that the CDD can significantly improve the pregnancy rate of infertile patients with PCOS, which might be associated with reduced insulin resistance, improved endometrial blood flow, and finally improved endometrial receptivity [18] . Although the CDD has been used clinically for gynaecological diseases for a long time, its mechanism of action is unclear because of its complex composition.
erefore, it is necessary to clarify the biological basis and molecular nature of the TCM decoction. Network pharmacology has recently been developed as a new strategy and technique for elucidating complex pharmacological problems for new drug discovery [19] . In recent years, the TCM Systems Pharmacology (TCMSP) database and analysis platform has emerged as an ideal information convergence of the absorption, distribution, metabolism, and excretion (ADME) properties, drug-likeness, drug targets, associated diseases, and interaction networks of traditional medicines [20] .
TCM decoctions have complex ingredients and multiple targets, and network pharmacology can predict novel compound targets and the potential pathways of action based on existing TCM decoctions and has helped clarify the mechanism of several TCM decoctions so far [21] [22] [23] .
In this study, we used the network pharmacology approach to explore the potential mechanism of action of CDD in treating PCOS. We first filtered the TCMSP database for active compounds of CDD and identified the targets, followed by mining for disease-related genes and network analysis of those genes ( Figure 1 ).
Methods

Chemical Components of Each Herb in CDD.
To screen the active ingredients of CDD, we used the TCMSP database (http://tcmspw.com/tcmsp.php) [20] . TCMSP is a unique systems pharmacology platform specifically designed for Chinese medicine that contains information on their ADME characteristics and captures the relationships between disease, targets, ingredients, and drugs [24] .
Pharmacokinetic Prediction of CDD.
CDD active ingredients were filtered mainly on the basis of oral bioavailability (OB), Caco-2 permeability (Caco-2), and drug-likeness (DL). OB, Caco-2, and DL are the three most key indicators of pharmacology. Specifically, the ingredients contained in the CDD meeting the criteria of OB ≥ 30%, Caco-2 ≥ 0.4, and DL ≥ 0.18 were chosen as candidate ingredients for further analysis.
OB refers to the percentage and rate of the release and absorption of active ingredients into the systemic blood circulation and is an important pharmacokinetic index of oral drugs [25] . It is also an important index to objectively evaluate the intrinsic quality of oral drugs [26] , which is particularly important in the drug administration of most oral Chinese herbal formulas [27] . DL is defined as a complex balance of structural features and various molecular properties, which determine whether the particular molecule is similar to the known drugs [26] . ese parameters, such as hydrogen bonding characteristics and hydrophobicity, mainly influence the behaviour of molecules in living organisms, which ultimately affects their transport properties, affinity for proteins, metabolic stability, and many other properties. Caco-2 permeability is widely used as a standard permeability screening assay for oral drug absorption related to drug permeability, which can predict the intestinal absorption of the ingredients and the fraction of the oral dose absorbed in humans [28] .
In this study, OB ≥ 30%, DL ≥ 0.18, and Caco-2 ≥ 0.4 were regarded as a threshold for filtering possible candidate drugs.
Potential Targets of the Chemical Components of CDD.
We chose the TCMSP database as the main source of component-target data and obtained the target protein names of each herb in CDD. Only the proteins that had interactions with the bioactive components in CDD we had already obtained were selected.
en, we converted the target protein names of the bioactive components of CDD into gene names with the species limited into "Homo sapiens" with the UniProt Knowledgebase (UniProtKB, http:// www.uniprot.org).
Known erapeutic Targets for PCOS.
We collected PCOS targets from two sources. One is the GeneCards database (https://www.genecards.org/), which is a searchable, integrative database that predicts human genes. e knowledgebase automatically integrates gene-centric data from ∼150 web sources, including genomic, transcriptomic, proteomic, genetic, clinical, and functional information [29] . Another resource was the gene map in the Online Mendelian Inheritance in Man (OMIM) database [30] (https://omim. org/, updated on November 15, 2019), which is a comprehensive, authoritative, and timely knowledgebase of human genes and genetic disorders in the human genome. We searched the OMIM database with the keyword "PCOS." 
Target Gene Prediction of CDD.
A total of 1433 potential targets from the 111 ingredients were retrieved from the TCMSP database (Figure 2 ). After eliminating the overlapping proteins, 118 related proteins were obtained and converted into gene names with the species limited into "Homo sapiens" based on the UniProtKB.
PCOS-Related Target Network.
Research has shown that PCOS is a genetic predisposing, complex polygenic, multifactorial disorder [7, 31] . In this study, we obtained 736 targets related to PCOS through the GeneCards database (https://www.genecards.org/) and the OMIM database (https://omim.org/).
PPI Network Analysis.
Among the above 736 PCOSrelated targets, CDD shared 44 common targets with PCOS ( Figure 3 ). e 44 putative therapeutic targets were imported into the STRING database to establish the putative therapeutic target PPI network. e "string_interaction.tsv" file was then imported into Cytoscape 3.7.2 to perform network analysis. e network had 44 nodes, which interacted with 361 edges. e average node degree is 16.4, and the average local clustering coefficient is 0.698. From yellow to green, the degrees of freedom increase, and the thicker edges suggest stronger interactions (Figure 4 ). Our results indicated that the top mutual target proteins have various beneficial functions for treating PCOS at the molecular level.
In our network, the degree of the greenness of the nodes is high, and the numbers of edges of the nodes are 37 for AKT1; 32 for IL-6; 29 for VEGFA; 28 for CCND1, STAT3, MAPK1, and MAPK8; 27 for ESR1; 26 for FN1; 25 for MMP9, CXCL8, and MAPK14; 23 for AR; and 22 for PPARG and HIF1A. ese results demonstrate that these targets are closely related to others in the network and consequently may play key roles in PCOS.
AKTs have been confirmed to play an important role in granulosa-lutein cell (GC) proliferation, and there is reciprocal feedback between AKT and androgen. is study showed that the high expression of AKT1 and AKT2 may cause GC dysfunction in PCOS patients through a possible relation with androgen [32] . Elevated serum levels of IL-6 in PCOS patients reflect low-grade chronic inflammation, which has been attributed to insulin resistance in PCOS [33] . In a PCOS rat model, increased expression of IL-6 and IL-11 was found to be associated with the AKT/STAT3 pathway. Increased levels of IL-6 and IL-11 stimulated adipocytes from adipose tissue of the PCOS rat model, which may activate AKT/STAT3 signalling and promote cell proliferation. Vascular endothelial growth factor (VEGF) plays an important role in the pathogenesis of many diseases. PCOS was also considered to be associated with high expression levels of VEGF. It was found that VEGF was a pivotal mediator of other factors to control ovary angiogenesis in women who underwent assisted reproductive technology (ART) procedures [34] .
e MAPK signalling pathway is one of the most important signal transduction pathways in organisms and mediates physiological and pathological processes, such as the growth, development, and differentiation of organisms. Studies have shown that the MAPK signalling pathway plays an important role in the proliferation of ovarian granulosa cells [35, 36] .
Research confirmed that PPARG rs709154 and ESR1 rs1999805 are significantly associated with PCOS risk in a Chinese population [37] . MMP9 may also be involved in the pathogenesis of PCOS [38] . HIF1A can induce glycolysis gene expression and promote anaerobic metabolism [39] . HIF-1a signalling was confirmed to be inhibited in a rat model with PCOS by increasing PHD activity [40] .
Putative erapeutic Compound-Putative erapeutic Target Network Construction.
e Merge function of Cytoscape 3.7.2 software was used to combine the DrugMol-Gene target network and the PCOS-Drug-Gene interaction network. e results showed that 111 compounds all together play a role in treating PCOS in the composite ( Figure 5 ). e targets of 111 putative therapeutic targets in the treatment of PCOS include AKT1, IL-6, VEGFA, CCND1, STAT3, MAPK1, MAPK8, ESR1, FN1, MMP9, CXCL8, MAPK14, AR, PPARG, and HIF1A.
GO Functional Enrichment Analysis.
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Figure 3: e CDD-PCOS-related drug targets. e blue octagon, yellow hexagon, green ellipse, mint green triangle, and red diamond represent disease, herbs, PCOS-related targets, CDD-related targets, and the common targets between CDD and PCOS, respectively. LOC108964933  PTX3  ANXA5  STK11   SREBF1   LCN2 RARRES2 INHBB  HSD17B6  PGRMC1  GHR  GNRHR CYP1A1  GHRH   ZNF143  UTS2   STXBP3  NPY  LOC110408762  IGF1R  APPL1  GLP1R   MIR103A1  MIR27B   CRH   LMNA  VIM   LIPE  KCNJ11   FEM1A  MIR93  MTNR1A   YAP1   PTEN   IGFBP2   SMAD4  MTNR1B  INHBA  SERPINC1  KLK3   GC  GCG IL1RN LHB IGFBP4 STARF2NGF   LGALS3  IL7   INSL3   LDLR   SET  PRKCZ  GJA4   MIR323A   ARNTL   MSR1   FBN3  APOA1   LINC01828   AGER   GAS5   GDF9   SRD5A1   RBP4   GATA6   ACEFTO  APOB  ALB  IRS2  FSHB  NAMPT  F5  CDH5  TNXB GSK3B  ESR1  IL4  RXRA   CASP9  DRD3   MAPK14  NOS2  LOC108863620  CDK2   IDE  FOXO1   TPM1   KRAS   TNFRSF1B   ESR2   PPARD  BCL2   MMP1   AKT1   NR3C2   MAPK1   SLC6A2   IL6   AR   TIMP1   DRD2   BAX   HIF1A   MMP9   CXCL8   KDR   CCND1   STAT3   PPARG   IGF2  NCOA2  VEGFA  ATP5F1B  PGR  ADRB2   HSD3B2   AKR1B1   CCL2   HSD3B1   ACHE   MAPK8   PON1   FN1   PLAU   CDKN1A   MIR106B   PEPC  LOC110386951  PCO1  PCO  SRA1  STON1-GTF2A1L   MIR25  MIR486-1  LOC108783649   CYP11B1 EPHA7  SMAD2  MEF2A   SCNN1G   SPARC   GSTM3  FBN1   PDCD4  CXCL10  SMAD1  GAB1  KISS1R  SREBF2  LPP  FERMT3  PRKAG3  PECAM1 LUM   MIR145  MIR16-2  MIR19B1   USP34  IFI27  PCGF1   PAX6  TPO MAPK7 GAPDH  DCN  MTR  NPPA   NDUFA6  SFRP4  CSF1   TFAM   HMGB1   AQP7  TRIB3   MIR486-2 INSL5   ANGPTL6  TXNIP  TH  BRCA1  PRKAA2 ACVR2B  GRB2  KRT18  NR1H2  PTK2  PIK3CG   SERPINA4   XPA  PPIG  KNG1   PLIN3  PRPF8  FGF13   HLA-B  CTLA4   GPC4   CYP2R1  GNB3   HSP90B1   GHSR  FAAH  TNFRSF11A  PAFAH1B1  TGFBR3  GZMB  PRKAR2B  TIMP3  HLA-DQB1   GP5  ZFX   ZNF318   GORASP1   CELF4   WDR48  IRX5  DNAH8  ZNF217  XIRP1   SORBS1   SLC4A3  SLPI  RAB8B  EPB41L3   BST2  ATOX1  OXA1L  KCNK5   RELB   PCK2  S100B  CAMK2G   DOCK1  CHKB  SFTPD  LMX1B   SMAD7  HBG2   CD63  SCN11A  SLC4A2   UGT2B15  COL27A1  NPPC   GYS2   ACAN   VCAN   ABCA1   HMGCR   APC  F13A1   BMP6  NRIP1   CSRNP1   MT-ATP6   GET3   LHFPL3   TTC21A   SERPINA13P   CZIB   LINC-ROR  LOC100506124  MEP1A   HSPA1A   SOCS3   CHI3L1   CYP3A7   AQP9   PNPLA2   COG2  BGLAP   ITGAX  MIR30C1  MIR30C2  LEPR  KISS1  BMP15  PNPLA3  INSIG2   NFIC   AGT  NQO1  CAT  CDK5  ERBB4   IFNG  TNFSF11   NM   INHBC  BMP8A   SFRP5   UCN3  MIR27A  MIR223   FADS2  IGFBP5   AKR1C1  LTA   FADS1  SAA1  IGFBP6  SMAD5   RAD54B   LOC109623489   CARTPT  GREB1  MIR155   TGFB1   THBS1  ANGPTL4  TPM2  SOCS1  HSD17B1  TBC1D4  FOXO3   PRDX2   IL6ST   ABCC8   PLIN1   CYP11B2   IL1R1  IL5   AQP8   CCL3   MDM2 GRIA2  TEP1   EGFR CDK4 CDK6 HGF   SLC30A10  CYB5A  ALPP  TAC3 HFE FGF19   CDKN1C  TGFA  IRF3  TNC  ACE2  PRKAA1  IFIH1  AGTR1  GFPT1   BFSP2 DSPP  HSPE1  TIMP4 SORCS1 INTS6 LINC01572 NPTN-IT1   CLEC16A  CHST4  GFPT2  CALCA   FANK1  HSD17B13   SELL  PER2  VTN  AGTR2  SDC4  TBL1XR1  ALDH3A2 TGIF1 CLOCK Evidence-Based Complementary and Alternative Medicinemigration, autophagy, and process utilizing autophagic mechanism ( Figure 6 ). e top 19 terms in the GO CC category were mainly enriched in nuclear chromatin, secretory granule lumen, cytoplasmic vesicle lumen, vesicle lumen, extracellular matrix, nuclear chromosome part, chromatin, glutamatergic synapse, platelet alpha granule lumen, platelet alpha granule, RNA polymerase II transcription factor complex, nuclear transcription factor complex, transcription factor complex, postsynaptic density, receptor complex, asymmetric synapse, neuron to neuron synapse, postsynaptic specialization, and basement membrane (Figure 7) . e top 19 terms in the GO MF category were mainly enriched in RNA polymerase II proximal promoter sequence-specific DNA binding, proximal promoter sequence-specific DNA binding, nuclear receptor activity, transcription factor activity, direct ligand regulated sequence-specific DNA binding, steroid hormone receptor activity, protein heterodimerization activity, receptor regulator activity, nuclear hormone receptor binding, hormone receptor binding, phosphatase binding, cytokine receptor binding, receptor ligand activity, chromatin binding, steroid binding, protein phosphatase binding, growth factor activity, cytokine activity, protein serine/threonine kinase activity, DNA-binding transcription activator activity, RNA polymerase II-specific, transcription coregulator activity, and RNA polymerase II transcription factor binding (Figure 8 ).
Pathway Analysis.
To clarify the biological actions of these targets, we performed KEGG analysis and pathway enrichment analysis with the RStudio (Bioconductor) database. We listed the genes of major PCOS putative therapeutic targets and imported them into RStudio to generate relevant pathways that might have an important influence on the biological process of CDD in treating PCOS. Pathways with an adjusted p value < 0.05 were considered significant.
A total of 123 signalling pathways were significantly enriched through pathway enrichment analysis. In the histogram and bubble diagram (Figure 9 ), the colour, size, and length of the nodes and bars were determined according to the numbers and p values of the related genes. e colour from blue to red reflects the adjusted p values from large to small, and the node size and bar length indicate the number of related genes. e histogram and bubble chart were separately arranged according to the p value and the number of related genes. According to the p value, the AGE-RAGE signalling pathway in diabetic complications, Kaposi sarcoma-associated herpesvirus infection, proteoglycans in cancer, endocrine resistance, hepatitis B, the IL-17 signalling pathway, prostate cancer, the prolactin signalling pathway, human cytomegalovirus infection, pancreatic cancer, the HIF-1 signalling pathway, and EGFR tyrosine kinase inhibitor resistance were within the top 12 terms. According to the number of related genes, Kaposi sarcoma-associated herpesvirus infection, proteoglycans in cancer, the PI3K-Akt signalling pathway, the AGE-RAGE signalling pathway in diabetic complications, human cytomegalovirus infection, hepatitis B, endocrine resistance, the IL-17 signalling pathway, prostate cancer, the HIF-1 signalling pathway, Epstein-Barr virus infection, and the prolactin signalling pathway were in the top 12 terms. e overlapping terms of the above lists included the AGE-RAGE signalling pathway in diabetic complications, endocrine resistance, the IL-17 signalling pathway, the prolactin signalling pathway, and the HIF-1 signalling pathway.
AGE-RAGE signalling may activate multiple intracellular signalling pathways involving protein kinase C and MAPKs and may influence NF-κB activity. Research has shown an association between PCOS and chronic inflammatory factors, proinflammatory cytokines such as interleukin-1, interleukin-6, interleukin-17 [41] [42] [43] , and tumour necrosis-α, and a variety of inflammationrelated genes, including VEGF, tissue factor, and RAGE [44, 45] .
Prolactin (PRL) is involved in a variety of biological functions, including osmotic regulation, reproduction, lactation, endocrinology and metabolism, growth and development, and immunomodulation. It is a polypeptide hormone secreted by the pituitary gland that regulates the female reproductive and endocrine system by activating pathways, including the MAPK and PI3K pathways [46] . Insulin resistance is a common type of endocrine resistance and is related to PCOS by deregulating the IRS-PI3K-Akt Evidence-Based Complementary and Alternative Medicinesignalling axis that integrates aberrant inflammatory responses [47] . A previous study also revealed that hypoxia-inducible factor-1a (HIF-1a) mediated endothelin-2 (ET-2) signalling and plays an important role in ovulation in rats and indicated that HIF-1a signalling is inhibited in a PCOS rat model by increasing PHD activity [40] .
Discussion
TCM plays a crucial role in the pharmaceutical industry, alternative medicine, and many other fields [48] [49] [50] . However, due to the complex chemical composition and unclear pharmacological mechanism of action of TCMs, it faces great obstacles in pharmacological research, quality control and supervision, modernization, and internationalization [51] .
TCM gives priority to the concept of holism in diagnosis and pays more attention to the overall changes in function.
e treatment is based on syndrome differentiation, emphasizing the recovery of overall function, which is similar to the network concept of network pharmacology [52] .
Traditional research methods on TCM mainly rely on pharmacochemical and pharmacological experiments, which have many problems, such as low data flux, low precision, long cycles, and high costs. e construction and development of a network pharmacology analysis platform, TCM database, and target prediction technology has brought new ideas and strategies for the study on the basis and mechanism of the pharmacodynamic substances of TCM to clarify characteristics such as the good curative effects, high safety profile, and multicomponents and multitargets of TCM [53] . ese developments also lead to a new direction for the modernization and internationalization of TCM [54] .
e combination of bioinformatics, computer technology, and experiments in the study of the pharmacodynamic components and potential targets of TCM broke through the deficiency of traditional studies is more rapid, flexible, and accurate and has been widely used in research on the network pharmacology of TCM [55] .
TCM has a long history in treating menstrual diseases and infertility related to PCOS and has achieved good effects [56]. In this study, several network pharmacology-based methods were used to predict potential targets. is approach provides new clues to exploring ethnopharmacology and herbal or even TCM formulas. rough the analysis of the putative therapeutic target network and biological functions in this study, the potential pharmacological and molecular mechanisms of CDD in treating PCOS were preliminary revealed.
In this study, the preliminary analysis based on network pharmacology provided a basis for subsequent studies on the pharmacodynamic ingredients and mechanisms of CDD. However, due to the limitations of the screening conditions and the TCM database, this study also has some shortcomings. Although a large number of targets and pathways were obtained through network pharmacology screening, these results must be verified by subsequent pharmacological experiments. In this study, the active components of CDD and their molecular mechanisms in PCOS were predicted overall, and a variety of potential therapeutic targets were explored. us, this study lays a good theoretical foundation for the next step of experimental verification and provides directions for further research on the molecular mechanism of PCOS.
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